Background. The major determinants of pulse wave velocity (PWV) in haemodialysis (HD) patients are not fully known. We studied chronic HD patients to assess the effect of cyclic variations in both hydration status and blood pressure on PWV. Methods. Twenty patients were examined along three consecutive HD sessions and interdialysis periods during a week-long period. Twenty healthy subjects and 20 chronic kidney disease (CKD) patients (stage 5) were evaluated as controls.
Introduction
A stiffening of the large arteries predicts adverse cardiovascular outcomes in the general population and in patients with cardiovascular disease [1] [2] [3] . Of the various direct and indirect methods for measuring arterial stiffness [4] , carotid-femoral or carotid-radial pulse wave velocity (PWV) has been recognized as the gold standard for arterial stiffness measurement because it is a direct measure of stiffness, has good reproducibility and has been supported by a number of highly quoted studies as an independent predictor of vascular outcomes [4] [5] [6] .
Recently, this technique has been widely used in renal patients [7, 8] . Because the major determinants of PWV are blood pressure [8, 9] and extracellular volume status [10, 11] , it is interesting that, in haemodialysis (HD) patients, continuous cyclic changes in hydration status and blood pressure determine life expectancy in these subjects. Thus, treatment with HD may alter PWV values. Specifically, the greater volume expansion that occurs after the long interdialysis period should cause an overestimation of patient PWV. However, there have been no studies to examine this possibility or the relationship between fluid removed during HD and changes in PWV. Therefore, true PWVs in dialysis patients remain unknown. This is a critical issue because knowledge of the true PWVs will allow evaluation of effective vascular risk in these patients.
In this work, we performed serial weekly measurements in chronic HD patients to evaluate the relationship between PWV and interdialysis fluid retention, and to evaluate changes in PWV induced by cyclic variations in hydration status and blood pressure.
Materials and methods

Patients
We studied a group of anuric (urinary output <200 mL/day) patients that had been on chronic, thrice weekly, 4-hour duration, standard bicarbonate HD for at least 1 year. Patients were required to have a stable (coefficient of variation <5%) PWV during three consecutive weekly measurements and a steady achieved dry weight in the previous 3 months (assessed by either inferior vena cava diameter or bioelectrical impedance analysis) to be enrolled into the study [12, 13] . Exclusion criteria were acute cardiovascular accidents and infections in the previous 3 months, advanced heart failure (New York Heart Association III to IV stages) or atrial fibrillation or arrhythmias, liver disease or ascites, acute or neoplastic illness and overt oedema. By using these same criteria, we also enrolled a group of 20 chronic kidney disease (CKD, stage 5) patients and a group of 20 healthy subjects. All of the subjects gave informed consent to the study.
Measurements
Patients underwent dialysis while lying in bed. They were studied for an entire week, during three consecutive HD sessions [HD-1: first session after the long interdialysis interval (~72 hours); HD-2 and HD-3: second and third sessions (after~48 hour intervals)] and at the relative interdialysis days. For each patient, all measurements were made immediately before (pre) and 1 hour after (post) the end of each dialysis session, and in the morning of each interdialysis day.
Blood pressure was measured using a mercury sphygmomanometre; the first and fifth Korotkoff sounds were used to identify systolic (SBP) and diastolic (DBP) blood pressures, respectively. The mean of three consecutive blood pressure measurements was recorded and used for statistical analysis. Body weight was detected using a bed balance with a scale of 0.05 kg (Tassinari, Cento, Italy).
PWV
The carotid-femoral PWV was measured with an automated system (Pulse Pen, DiaTecne, Milan, Italy) using the foot-to-foot method. The carotid and femoral waveforms were acquired simultaneously with two pressure-sensitive transducers, and the transit time of the pulse was calculated by the system software. The distance between the two arterial sites was measured on the body using a tape measure, and the PWV was calculated as the distance divided by time (metres per second). At least 12 successive readings were used for analysis to cover a complete respiratory cycle. All PWV measurements were performed by the same operator, and the mean of three consecutive measures (each taken 5 minutes apart) was used for statistical analyses; if the coefficient of variation (CV) for PWV was >5%, the patient was excluded from the study (no patient showed CV for PWV >5%).
The observed PWV (PWV-o) was normalized (PWV-n) for SBP and heart rate (HR) according to the formula: PWV-n = PWV-o × (SBP-n/ SBP-o) × (HR-n/HR-o), where SBP-n is the normalized SBP (reference value = 130 mmHg), SBP-o is the observed SBP, HR-n is the normalized HR (reference value = 72 b/min) and HR-o is the observed HR. Finally, to obtain the actual PWV that the patients experienced during the entire week, we used the trapezoidal rule to calculate the area under the curve for all weekly values of PWV [14] .
Statistics
All values are reported as means ± SD. Intra-group comparisons were made by paired Student's t-tests or analysis of variance (ANOVA) for repeated measures, followed by the Newman-Keuls as a post hoc test. Unpaired Student's t-tests were used for inter-group comparisons. Linear regression analysis and chi-square tests were also performed. Two-tailed P-values <0.05 were considered significant.
Results
The study was performed in 20 patients on chronic HD (12 men, 8 women) having a mean age of 56.2 ± 5.6 years and a body mass index of 24.5 ± 0.6 kg/m 2 . The study group did not differ from controls, except for blood pressure, serum creatinine and haemoglobin (Table 1) .
Dry weights in HD patients were assessed by inferior vena cava diameter values (8.6 ± 0.5 mm/m 2 ) and by body impedance analysis-derived percent total body water (TBW = 53 ± 2%) obtained at the end of the last HD session before the study week. The duration of each HD session was constant during the study period (235 to 245 minutes). During HD, no patient had cramps or arterial hypotension, which was defined as SBP or DBP <100 and 60 mmHg, respectively. Thus, no patient required intravenous infusion of saline and/or plasma expanders. We found a strict correlation between intradialysis body weight loss and effective ultrafiltration rate (UF) volume (r = 0.986; P < 0.001). The achieved UF was significantly greater during HD-1 than during HD-2 and HD-3 (Table 2) ; as a consequence, intradialysis body weight loss was greater during HD-1 than during the other two dialysis periods (Table 2 ). SBP and DBP were not different at the beginning of the three sessions, and both declined during each of the dialysis treatments (P < 0.05) ( Table 2) .
Observed PWV values were higher before the first dialysis session of the week compared with the other two dialysis sessions; thereafter, it declined during each dialysis session. PWV-n values showed similar changes ( Table 2 ). Figure 1 shows the cyclic changes in PWV during the week-long period in HD patients. Intradialysis changes in PWV were similar during the three dialysis sessions; consequently, all post-dialytic PWV values [8.8 ± 4.7, 8.0 ± 4.8 and 8.1 ± 4.9 m/sec; P = not significant (NS)] were lower with respect to pre-dialytic levels. During the interdialysis period, PWV increased again with respect to the previous post-HD value, measuring 11.9 ± 3.3, 11.2 ± 2.8, 11.3 ± 2.2 and 13.2 ± 4.2 m/sec at the first, second, third and fourth interdialysis days, respectively. To possibly explain the changes in PWV, we found a significant relationship between dialysis UF rate and PWV reduction (y = 1.22 × + 1.54; r = 0.465; P < 0.001) ( Figure  2, upper panel) ; a significant indirect relationship between dialysis UF rate and post-dialysis PWV-n was also found (y = 14.26 × −1.82; r = −0.654; P < 0.0001) (Figure 2 , lower panel). Interestingly, the changes in SBP during dialysis treatment were not significantly correlated with PWV reduction (y = 5.29 × −0.020; r = 0.062; P = NS) ( Figure 3, upper panel) , although there was a small but significant indirect relationship between blood pressure decline and post-dialysis PWV-n (y = 10.45 × −0.071; r = −0.267; P < 0.05) (Figure 3, lower panel) .
Use of the trapezoidal rule to calculate the area under the curve for PWV revealed a mean value of 12.6 ± 6.5 m/sec for PWV-o and 10.8 ± 5.7 m/sec for PWV-n. Thus, the value that best identifies the mean weekly PWV in HD patients is found during the second and third dialysis-free days of the week; in addition, the PWV value detected dur- Influence of haemodialysis on variability of pulse wave velocity in chronic haemodialysis patients 1581 ing the dialysis days was the value measured before the last dialysis of the week. As a consequence, the percentage of HD patients with PWV-n above the safe threshold of 12 m/ sec was very high in the pre-HD phases (around 75-80%), but this was reduced during the post-HD period (~20%) and the interdialysis days (~25-35%). Interestingly, PWV-n was 6.3 ± 2.9 m/sec in healthy controls (P = 0.009 vs. CKD; P = 0.0001 vs. HD) compared with 9.9 ± 4.2 m/sec in CKD subjects (P = NS vs. HD). In fact, 25% of CKD subjects had a PWV above the threshold of 12 m/sec, while 39% of HD patients (chi-square: P = NS vs. CKD) had a weighted PWV value over this safe threshold ( Figure 4) . Differences between the groups of HD patients with a weekly PWV above and below the threshold of 12 m/sec are shown in Table 3 .
Discussion
In both healthy subjects and CKD patients, PWV measurements are stable over time and do not exhibit a cyclical variability [6] [7] [8] . However, serial measurements of PWV have not been explored in HD patients who experience cyclic variations in body hydration status and blood arterial pressure, both major determinants of PWV. The present study showed for the first time in dialysis patients that the individual PWV levels undergo cyclic changes during each weekly period, by decreasing during the dialysis treatment and then increasing during the periods between dialyses sessions. Although we showed for the first time cyclic PWV changes in HD patients, this is not surprising because a relationship between volume overload and PWV has already been shown in this patient population [5] . However, this previous study had some limitations, and results were conflicting [5] . For example, the data collection was restricted to only one pre-dialysis and one interdialysis measurement, and the subjects were given a concomitant treatment with an angiotensin-converting enzyme inhibitor. In addition, it has been suggested that logarithm increments in PWV are related to blood pressure in a linear fashion [12, 13] . Thus, the present study provides new information on the relationship between hydration status, blood pressure and PWV in HD patients by examining serial changes in volume status, blood pressure and PWV during both the intra-and interdialysis phases of a weeklong dialysis treatment. We found a striking parallel between hydration status, as indicated by the body weight changes, and blood pressure as well as PWV; all decreased during each dialysis treatment and then progressively increased during the interdialysis periods. Thus, both the hydration status and blood pressure changes were related to PWV. The influence of each of these factors on PWV, however, appeared to be different. For example, when the observed PWV was normalized for blood pressure and heart rate, the cyclic changes in PWV were unmodified with only minor changes in single values during each of the repeated measurements during the week. In addition, comparison of dialysis UF rate as well as blood pressure with PWV revealed that changes in body water volume status were strongly correlated with PWV changes during dialysis and with the lowest PWV values obtained after dialysis treatment; changes in blood pressure were only weakly and inversely related to post-dialysis PWV levels. Taken together, these observations suggest that hydration status and its frequent changes appear to be the major determinants of both PWV and changes in PWV in HD patients, and that these changes are independent of blood pressure [12, 13] .
It was recently shown that PWV values >12 m/sec in dialysis patients are associated with a poorer outcomes [14] , indicating that this level should be considered as a safe threshold for PWV during dialysis. We evaluated a weighted weekly value of PWV, as measured by the area under the curve of PWV, in order to provide a consistent weighted median measure of the week. With this measure, we found that 39% of HD patients had a mean PWV above the considered safe threshold, which was not significantly different from the pre-dialysis CKD patients (25%). Thus, even though these patients experienced very high PWV levels and frequent short-term changes in PWV, these values probably represent realistic PWVs experienced by dialysis patients. Although these values are abnormal, they were not different from those in the pre-dialysis patients. This represents novel information of clinical relevance since changes in PWV level appear to significantly affect individual outcomes in uremic patients [10, 11, 15, 16] ; indeed, it has also been reported that increased aortic PWV is associated with poorer outcomes in dialysis patients [9, 10] . In our study, the subgroups of HD patients with PWV values above and below the safe threshold were similar, except for age and the number of prescribed antihypertensive drugs (Table 3 ). The duration of dialysis, hydration status and blood pressure were also similar between the subgroups and were probably not related to the difference in PWV. Although these observations are puzzling, the present study was not designed to specifically test hypotheses in this area. Nevertheless, these findings suggest a working hypothesis that a major determinant Table 3 . Characteristics of HD patient subgroups having normal or high weekly PWV of absolute PWV in chronic HD patients may be arterial system damage rather than hydration status, blood pressure or dialysis itself. Interestingly, it has been shown that PWV in large elastic-type arteries is strongly related to arterial stiffness associated with increased vascular calcifications [17] . In addition, the onset of abnormal PWV occurs early in the course of CKD and progressively worsens as renal function deteriorates [18, 19] . Indeed, higher calcium scores in HD patients are associated with higher PWVs, and this represents a major determinant of PWV [20] . In any case, differences between single measures of PWV during the week and weekly values raise the question of which measurement is most representative of true PWV in HD patients. Our data show that the second and the third dialysis-free days (Day 4 and 6 of the week) represent the time point when PWV is very close to the weekly middle value.
In conclusion, our study shows for first time that HD patients have a weekly cyclic variation in PWV and that the major determinant of these variations is the changes in hydration status. In addition, even if all the patients had a PWV above the safety threshold of 12 m/sec during the week, only a small portion had weekly weighted PWV values above this level while most remained under this risk level. We also found that the best point to measure PWV in HD patients is during the interdialysis days. Additional studies will be necessary to explore the relation between these cyclic PWV variations as well as weekly PWV measurements and patient outcome.
